As an effective therapeutic option for both obesity and DM, bariatric surgeries are beneficial far beyond contributing to weight loss but also recovering islet function by reversing metabolic disorders and normalizing the levels of glucagon-like peptide 1 (GLP-1) and peptide YY (PYY) (27). The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.